Axon Enterprise
AXON
#534
Rank
โ‚น4.616 T
Marketcap
โ‚น56,824
Share price
4.43%
Change (1 day)
-20.67%
Change (1 year)

Revenue for Axon Enterprise (AXON)

Revenue in 2026 (TTM): โ‚น267.43 Billion

According to Axon Enterprise 's latest financial reports the company's current revenue (TTM ) is โ‚น284.27 Billion. In 2025 the company made a revenue of โ‚น249.51 Billion an increase over the revenue in the year 2024 that were of โ‚น178.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Axon Enterprise from 2001 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น267.43 B7.18%
2025 โ‚น249.51 B39.67%
2024 โ‚น178.65 B37.29%
2023 โ‚น130.12 B32.15%
2022 โ‚น98.46 B53.23%
2021 โ‚น64.26 B29.03%
2020 โ‚น49.80 B31.56%
2019 โ‚น37.85 B28.88%
2018 โ‚น29.37 B33.8%
2017 โ‚น21.95 B20.43%
2016 โ‚น18.22 B38.61%
2015 โ‚น13.15 B26.12%
2014 โ‚น10.42 B22.45%
2013 โ‚น8.51 B35.53%
2012 โ‚น6.28 B31.93%
2011 โ‚น4.76 B22.26%
2010 โ‚น3.89 B-19.47%
2009 โ‚น4.83 B8.4%
2008 โ‚น4.46 B12.89%
2007 โ‚น3.95 B31.8%
2006 โ‚น2.99 B39.74%
2005 โ‚น2.14 B-26.73%
2004 โ‚น2.92 B163.09%
2003 โ‚น1.11 B135.9%
2002 โ‚น0.47 B42.74%
2001 โ‚น0.33 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
XBiotech
XBIT
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น3.29 B-98.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น9.56 B-96.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น226.36 B-20.37%๐Ÿ‡บ๐Ÿ‡ธ USA